Dr. Ina Sarel
Vice President of Research and Development
Ina has broad cell-therapy experience from international biotechnology companies in Israel and the US. Previously, she was director of research and development at TheraVitae, project manager at Proneuron Biotechnologies, and senior scientist at Cambrex, USA, where she developed a stem cell research product—Normal Human Neural Progenitors (NHNP) and Medium, which is currently commercialized by Lonza. Ina received an MSc degree in endocrinology from the Hebrew University in Jerusalem and a PhD degree in neuroendocrinology from Boston University, USA.